Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Adapalene Gel 0.1% in Acne Vulgaris
NCT04329403Phase 3Withdrawn
- Sponsor
- Aurobindo Pharma Limited
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of adapalene in acne vulgaris, sponsored by Aurobindo Pharma Limited. Planned start Jul 2020; status: withdrawn.
02
Drugs
adapalene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04329403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04329403.